FDA recalls blood pressure drugs after quality test failure

More than 3,700 bottles of blood pressure pills were recalled nationwide, according to an FDA enforcement report.

Consumers are being urged to check their medicine cabinets after more than 3,700 bottles of blood pressure medication sold across the country were recalled last month because the tablets did not break down and dissolve as they should, according to an enforcement report from the Food and Drug Administration.

Macleods Pharma USA Inc., based in New Jersey, initiated the recall on Oct. 7 for Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide tablets. The action was later classified as a Class II recall on Oct. 26, indicating the pills could lead to temporary or medically reversible health effects, while the chance of serious harm was considered low.

The recalled tablets came in 40 mg, 10 mg and 12.5 mg strengths and were packaged in 30-count or 90-count bottles. In total, the report said, 3,528 bottles of the 30-count version and 216 bottles of the 90-count version were pulled from the market.

The FDA said the recall stemmed from failed dissolution specifications, meaning the tablets did not dissolve properly as required.

According to the Mayo Clinic, these prescription medicines are used to treat hypertension, or high blood pressure.

No additional details were released. NBC Chicago said it has contacted Macleods Pharma for comment.